Skip to main content
Erschienen in: International Urogynecology Journal 4/2019

01.04.2019 | Original Article

Route of hysterectomy during minimally invasive sacrocolpopexy does not affect postoperative outcomes

verfasst von: Emily R. W. Davidson, Tonya N. Thomas, Erika J. Lampert, Marie Fidela R. Paraiso, Cecile A. Ferrando

Erschienen in: International Urogynecology Journal | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Hysterectomy can be performed during sacrocolpopexy, but there are limited studies comparing the effect of route of hysterectomy on adverse events. We hypothesized there would be no difference in adverse events or patient-reported outcomes in women who underwent minimally invasive sacrocolpopexy with either vaginal or supracervical hysterectomy.

Methods

This was a retrospective chart review with a cross-sectional survey component sent to all consenting patients. Patients were identified by procedure code for sacrocolpopexy and hysterectomy from January 2005 to June 2016.

Results

Of the 161 subjects meeting the inclusion criteria, 116 underwent supracervical and 45 vaginal hysterectomy. Overall incidence of perioperative adverse events was low. Vaginal hysterectomy cases were faster (276 vs. 324 min, p < 0.001) and had higher rates of postoperative stress incontinence (22 vs. 9%, p = 0.03). Thirty-one (19%) of all subjects had recurrent prolapse; 10 (6%) underwent repeat surgery. Three (1%) subjects had a mesh exposure (no difference between groups), all treated conservatively. Ninety-six (60%) subjects responded to the survey with a median follow-up of 56 (9–134) months. Ninety-one percent (87) of respondents reported being better since surgery, and 91% (87) reported they would choose the surgery again. Twenty-eight percent (27) reported a surgery-related complication including pain, urinary and bowel symptoms; 8% (8) reported evaluation for recurrent prolapse symptoms, all treated conservatively; 4% (4) of respondents reported a mesh exposure.

Conclusions

Incidence of adverse events is low and not different between patients undergoing minimally invasive sacrocolpopexy with concurrent supracervical or vaginal hysterectomy. One in three patients report pelvic floor symptoms postoperatively, but long-term satisfaction is high.
Literatur
1.
Zurück zum Zitat Nygaard I, Brubaker L, Zyczynski HM, Cundiff G, Richter H, Gantz M, et al. Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse. JAMA. 2013;309(19):2016–24.CrossRefPubMedPubMedCentral Nygaard I, Brubaker L, Zyczynski HM, Cundiff G, Richter H, Gantz M, et al. Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse. JAMA. 2013;309(19):2016–24.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Unger CA, Paraiso MF, Jelovsek JE, Barber MD, Ridgeway B. Perioperative adverse events after minimally invasive abdominal sacrocolpopexy. Am J Obstet Gynecol. 2014;211(5):547 e1–8.CrossRef Unger CA, Paraiso MF, Jelovsek JE, Barber MD, Ridgeway B. Perioperative adverse events after minimally invasive abdominal sacrocolpopexy. Am J Obstet Gynecol. 2014;211(5):547 e1–8.CrossRef
3.
Zurück zum Zitat Osmundsen BC, Clark A, Goldsmith C, Adams K, Denman MA, Edwards R, et al. Mesh erosion in robotic sacrocolpopexy. Female Pelvic Med Reconstr Surg. 2012;18(2):86–8.CrossRefPubMed Osmundsen BC, Clark A, Goldsmith C, Adams K, Denman MA, Edwards R, et al. Mesh erosion in robotic sacrocolpopexy. Female Pelvic Med Reconstr Surg. 2012;18(2):86–8.CrossRefPubMed
4.
Zurück zum Zitat Tan-Kim J, Menefee SA, Luber KM, Nager CW, Lukacz ES. Prevalence and risk factors for mesh erosion after laparoscopic-assisted sacrocolpopexy. Int Urogynecol J. 2011;22(2):205–12.CrossRefPubMed Tan-Kim J, Menefee SA, Luber KM, Nager CW, Lukacz ES. Prevalence and risk factors for mesh erosion after laparoscopic-assisted sacrocolpopexy. Int Urogynecol J. 2011;22(2):205–12.CrossRefPubMed
5.
Zurück zum Zitat Nosti PA, Carter CM, Sokol AI, Tefera E, Iglesia CB, Park AJ, et al. Transvaginal versus transabdominal placement of synthetic mesh at time of sacrocolpopexy. Female Pelvic Med Reconstr Surg. 2016;22(3):151–5.CrossRefPubMed Nosti PA, Carter CM, Sokol AI, Tefera E, Iglesia CB, Park AJ, et al. Transvaginal versus transabdominal placement of synthetic mesh at time of sacrocolpopexy. Female Pelvic Med Reconstr Surg. 2016;22(3):151–5.CrossRefPubMed
6.
Zurück zum Zitat Srikrishna S, Robinson D, Cardozo L. Validation of the patient global impression of improvement (pgi-i) for urogenital prolapse. Int Urogynecol J. 2010;21(5):523–8.CrossRefPubMed Srikrishna S, Robinson D, Cardozo L. Validation of the patient global impression of improvement (pgi-i) for urogenital prolapse. Int Urogynecol J. 2010;21(5):523–8.CrossRefPubMed
7.
Zurück zum Zitat Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol. 2003;189(1):98–101.CrossRefPubMed Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol. 2003;189(1):98–101.CrossRefPubMed
8.
Zurück zum Zitat Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (pfdi-20 and pfiq-7). Am J Obstet Gynecol. 2005;193(1):103–13.CrossRefPubMed Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (pfdi-20 and pfiq-7). Am J Obstet Gynecol. 2005;193(1):103–13.CrossRefPubMed
9.
Zurück zum Zitat Sandvik H, Espuna M, Hunskaar S. Validity of the incontinence severity index: comparison with pad-weighing tests. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17(5):520–4.CrossRefPubMed Sandvik H, Espuna M, Hunskaar S. Validity of the incontinence severity index: comparison with pad-weighing tests. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17(5):520–4.CrossRefPubMed
10.
Zurück zum Zitat Rogers RG, Espuña Pons ME. The pelvic organ prolapse incontinence sexual questionnaire, IUGA-revised (pisq-ir). Int Urogynecol J. 2013;24(7):1063–4.CrossRefPubMed Rogers RG, Espuña Pons ME. The pelvic organ prolapse incontinence sexual questionnaire, IUGA-revised (pisq-ir). Int Urogynecol J. 2013;24(7):1063–4.CrossRefPubMed
11.
Zurück zum Zitat Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (redcap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.CrossRefPubMed Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (redcap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.CrossRefPubMed
12.
Zurück zum Zitat SAS Institute I. Jmp®. 14 ed. Cary, NC1989-2007. SAS Institute I. Jmp®. 14 ed. Cary, NC1989-2007.
13.
Zurück zum Zitat Myers EM, Siff L, Osmundsen B, Geller E, Matthews CA. Differences in recurrent prolapse at 1 year after total vs supracervical hysterectomy and robotic sacrocolpopexy. Int Urogynecol J. 2015;26(4):585–9.CrossRefPubMed Myers EM, Siff L, Osmundsen B, Geller E, Matthews CA. Differences in recurrent prolapse at 1 year after total vs supracervical hysterectomy and robotic sacrocolpopexy. Int Urogynecol J. 2015;26(4):585–9.CrossRefPubMed
14.
Zurück zum Zitat Vandendriessche D, Sussfeld J, Giraudet G, Lucot JP, Behal H, Cosson M. Complications and reoperations after laparoscopic sacrocolpopexy with a mean follow-up of 4 years. Int Urogynecol J. 2017;28(2):231–9.CrossRefPubMed Vandendriessche D, Sussfeld J, Giraudet G, Lucot JP, Behal H, Cosson M. Complications and reoperations after laparoscopic sacrocolpopexy with a mean follow-up of 4 years. Int Urogynecol J. 2017;28(2):231–9.CrossRefPubMed
Metadaten
Titel
Route of hysterectomy during minimally invasive sacrocolpopexy does not affect postoperative outcomes
verfasst von
Emily R. W. Davidson
Tonya N. Thomas
Erika J. Lampert
Marie Fidela R. Paraiso
Cecile A. Ferrando
Publikationsdatum
01.04.2019
Verlag
Springer International Publishing
Erschienen in
International Urogynecology Journal / Ausgabe 4/2019
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-018-3790-4

Weitere Artikel der Ausgabe 4/2019

International Urogynecology Journal 4/2019 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.